P

Passage Bio
D

PASG

4.76000
USD
-0.26
(-5.18%)
مغلق
حجم التداول
2,111
الربح لكل سهم
-14
العائد الربحي
-
P/E
-0
حجم السوق
15,316,776
المقالات
المزيد

العنوان: Passage Bio Inc

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to target critical underlying pathologies in these conditions. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target the critical underlying pathology of neurodegenerative diseases. The pipeline having PBFT02.